Showing results 11 to 12 of 12
Issue Date | Title | Journal Title |
---|---|---|
2020 | Repotrectinib Exhibits Potent Antitumor Activity in Treatment-Naïve and Solvent-Front-Mutant ROS1-Rearranged Non-Small Cell Lung Cancer | CLINICAL CANCER RESEARCH |
2019 | Targeting YAP to overcome acquired resistance to ALK inhibitors in ALK-rearranged lung cancer | EMBO MOLECULAR MEDICINE |